DiaMedica Therapeutics
DMAC
DMAC
57 hedge funds and large institutions have $28.5M invested in DiaMedica Therapeutics in 2025 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.8% more ownership
Funds ownership: 15.74% → 17.53% (+1.8%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
22% less capital invested
Capital invested by funds: $36.5M → $28.5M (-$8.06M)
Holders
57
Holding in Top 10
1
Calls
$57K
Puts
$9K
Top Buyers
| 1 | +$955K | |
| 2 | +$689K | |
| 3 | +$587K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$414K |
| 5 |
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture
Dallas,
Texas
|
+$323K |
Top Sellers
| 1 | -$882K | |
| 2 | -$413K | |
| 3 | -$219K | |
| 4 |
Citigroup
New York
|
-$82.3K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$36.4K |
